Tag: WAVX

Blue Horseshoe Stocks: PBR, PTIE Updates, & More

Petroleo Brasiliero S.A. (Petrobras) PBR Options

Our long-time favorite options-trading target, PBR, after taking a significant beating over the past couple of weeks, finally found support in the 10.80’s and began to bounce back during yesterday’s session. It marked the lowest PPS we’ve witnessed since we first began watching this play. We’re also seeing a moderate gap-up in premarket trading this morning. We want to see it achieve higher lows and higher highs over the next few sessions to confirm the trend.

We’ve experienced many dips and rips with PBR over the roughly 7-month period we’ve been tracking it, and as we usually do in this situation, we’re going to attempt to take advantage of the recovery pattern we’re observing. For a specific idea, we want to radar the November 14th 12.00 Calls.

Pain Therapeutics, Inc. PTIE 

The huge gap down we noticed in the premarket yesterday is what drew us to include PTIE in our morning report. We mentioned that we’d monitor it for a eventual bounce and it came almost immediately. The stock saw a brief morning low of 1.61, and bounced back as high as 2.14 in the afternoon.

It marked a 33% intraday move, and intrigued us enough to want to continue watching as the week progresses.

The cause of the enormous gap-down was the nixing of an agreement the company had with Pfizer to develop and commercialize its Remoxy pain medication. It’s worth it to note that despite the huge setback, the stock came into this week with an analyst price target of 8.00/share.

Ascent Solar Technologies, Inc. ASTI

ASTI is one we’ve had an eye on for the past several weeks as it has searched out its own lows, and after reaching a bottom in the 1.40-range a couple of weeks ago, the stock has been making some nice strides to recover lost ground.

This morning the stock is gapping up over $2 on the heels of an early morning PR relating to a key milestone in a potentially lucrative Chinese joint venture.

Extended Watchlist:
DRYS, FRO, JNUG, WAVX, WMGIZ 

Blue Horseshoe Stocks: RSH Update & More

Radio Shack Corp. RSH

RSH has made regular appearances in our reports over the past couple of months, starting in the beginning of August, when we caught the stock off of its 52-week low of .55.

Following a major run-up to the 1.60-range on August 29th, the stock has been under a general consolidation amid bankruptcy rumors. This week, the company was hinting at possible refinancing deal that would allow them to avoid that situation for the time being, and this morning, that deal was confirmed.

As a result, the stock is up significantly today, having traded as high 1.65 in the premarket. We’re going to want to see support hold at previous resistance points at 1.15 and 1.30. Already, at today’s early highs, we’re seeing more than a 100% increase off of the lows we observed following our most recent RSH alert (.80)

Rockwell Medical, Inc. RMTI

RMTI is another morning gapper that we’re going to place on watch today. With the stock coming off of a recent bottom, it’s going to be interesting to see how today’s development affects its price action.

The company put out a hefty PR this morning regarding a commercialization/distribution deal with Baxter Healthcare (BAX):

WIXOM, Mich., Oct. 3, 2014 (GLOBE NEWSWIRE) — Rockwell Medical, Inc. (RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis, announced today that it has signed an exclusive agreement with Baxter Healthcare Corporation, a subsidiary of Baxter International Inc. (BAX), to commercialize Rockwell’s hemodialysis concentrate product line in the U.S. and in select overseas markets.>> VIEW PR

BioCryst Pharmaceuticals, Inc. BCRX

BCRX appeared on Wednesday in our extended watchlist, and what has followed has been two fruitful sessions in a row. From a low of 9.89 on Wednesday, we witnessed as the stock bulled its way into yesterday’s close, reaching a daily high of 11.49, a solid 16% overnight increase.

Inovio Pharmaceuticals, Inc. INO

Speaking of pharma plays, INO, a stock that has appeared several times in our reports recently, is also making moves concurrently with the present concern over the Ebola virus outbreak. The company actually has a Ebola vaccine with which they’ve reported success in treating animals with the deadly virus. Anything to do with Ebola is getting a lot of attention at present, and INO is no exception.

Side Note:

Jobs numbers were out this morning, to a positive reception. We will subsequently be looking for dip-and-rip opportunities with regard to options trading. Friday is characteristically a day when premiums start to come down as a result of time decay, with expirations looming. We’re looking at potential opportunities trading Calls in plays like SPY, AA, ISRG, & GPRO.

Extended Watchlist:
HALO, JBLU, WAVX, IAG, SFUN, NXTD

Blue Horseshoe Stocks: Another Week Off to a Great Start

Intuitive Surgical, Inc. ISRG
–
After outlining some potential opportunities in the options chain, ISRG behaved as we hoped it might yesterday, and delivered in a big way.

The Weekly $385 Calls made a 22% move from 21.50-26.20. The Weekly $395’s fared even better, with a daily low of 11.60 giving way to a 17.02 close; good for up to 47% in profits.

There were even big-time chances on the longer term Calls we mentioned, for example, the October $420 Calls ranged from 17.36 all the way up to 24.60, a 42% rip.

We’ll continue to track the Call-side on ISRG as provided by a continued trend off of its recent relative bottom.

Solar Wind Energy tower, Inc. SWET

We tried to give our readers advance notice on SWET and the chart’s potential for a nice move up, first bringing it up on Friday, and focusing in again in yesterday morning’s report. We were happy to see things take a northerly turn to kick off the week, as the stock ran 18% intraday from .0193 and reaching .0227, a solid 23% increase from Friday’s low of .0185.

We still like the look of things with regard to the chart, and with oil & gas spiking it can provide a boost to solar plays like this one, as we’re now witnessing. We’ll keep SWET on our radar screens as the week progresses, and we wouldn’t be surprised to see further opportunities come down the pipe.

GW Pharmaceuticals, Inc GWPH

GWPH was a stock that we were tracking along with the large group of cannabis-related stocks earlier this year. On January 27th, we had it listed among several plays that we felt could provide continued opportunities, and over the past few months, it has become a real success-story for us.

Coming from the $50-range back in late January, the stock made an extremely nice move to the tune of roughly 65% up to the low $80’s.

After a period of consolidation in which it came all the way back down to find support at 41.86 (Apr 15th), and we’ve now seen it trend up once again, reaching 79.24 on Thursday, an added 89% increase. So the opportunities have certainly been present, and the stock is gapping up even higher in the pre-market on the heels of an apparently well-received PR released at 7am this morning.

We also want to radar the $80-85 Calls on the options side of things, to maximize our potential even further on this play.

LONDON, June 17, 2014 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (GWPH) (GWP.L) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced physician reports of efficacy and safety data on 27 children and young adults with treatment-resistant epilepsy who have been treated with GW’s investigational cannabidiol (CBD) product candidate, Epidiolex(R), for a period of 12 weeks. >> FULL PR

Extended Watchlist:
DDD ($52-53 Calls), FST, WAVX, AGRX, GIGA, PNBK